Haleon plc (NYSE:HLN) Receives $10.95 Average Price Target from Analysts

Haleon plc (NYSE:HLN - Get Free Report) has earned a consensus rating of "Moderate Buy" from the seven research firms that are covering the company, MarketBeat Ratings reports. Four investment analysts have rated the stock with a hold rating, two have assigned a buy rating and one has issued a strong buy rating on the company. The average 1 year price target among brokerages that have issued ratings on the stock in the last year is $10.95.

A number of brokerages have recently commented on HLN. Morgan Stanley lowered Haleon from an "overweight" rating to an "equal weight" rating in a report on Friday, January 10th. Sanford C. Bernstein downgraded Haleon from an "outperform" rating to a "market perform" rating in a research report on Wednesday, January 8th. Finally, HSBC reiterated a "hold" rating on shares of Haleon in a report on Wednesday.

Haleon Stock Down 1.7 %

NYSE HLN traded down $0.18 during trading hours on Friday, reaching $10.49. 4,578,581 shares of the company's stock were exchanged, compared to its average volume of 10,200,998. The company has a debt-to-equity ratio of 0.44, a quick ratio of 0.58 and a current ratio of 0.84. The company has a market capitalization of $47.48 billion, a price-to-earnings ratio of 30.87, a price-to-earnings-growth ratio of 2.82 and a beta of 0.28. The company's 50-day moving average is $9.63 and its two-hundred day moving average is $9.85. Haleon has a one year low of $7.89 and a one year high of $10.80.

Haleon (NYSE:HLN - Get Free Report) last issued its quarterly earnings data on Thursday, February 27th. The company reported $0.05 EPS for the quarter. The business had revenue of $3.54 billion for the quarter, compared to analyst estimates of $3.38 billion. Haleon had a net margin of 10.85% and a return on equity of 14.76%. On average, analysts forecast that Haleon will post 0.43 EPS for the current fiscal year.

Haleon Increases Dividend

The business also recently announced a -- dividend, which will be paid on Thursday, June 5th. Investors of record on Friday, April 25th will be issued a dividend of $0.1166 per share. This represents a yield of 1.6%. The ex-dividend date is Friday, April 25th. This is a positive change from Haleon's previous -- dividend of $0.05. Haleon's dividend payout ratio is presently 58.97%.

Institutional Investors Weigh In On Haleon

A number of institutional investors and hedge funds have recently made changes to their positions in the stock. Brucke Financial Inc. bought a new position in shares of Haleon in the 4th quarter valued at about $96,000. Forum Financial Management LP increased its position in Haleon by 52.2% during the fourth quarter. Forum Financial Management LP now owns 30,705 shares of the company's stock worth $293,000 after buying an additional 10,530 shares during the last quarter. Vise Technologies Inc. raised its stake in Haleon by 21.5% in the fourth quarter. Vise Technologies Inc. now owns 59,125 shares of the company's stock valued at $564,000 after buying an additional 10,468 shares during the period. Principal Street Partners LLC acquired a new stake in shares of Haleon in the fourth quarter valued at approximately $472,000. Finally, Wolverine Trading LLC acquired a new position in shares of Haleon during the 4th quarter worth approximately $208,000. Institutional investors own 6.67% of the company's stock.

Haleon Company Profile

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands.